Clinical trial

Alpha-Adrenoceptor Vascular Function In Chronic Kidney Disease Focus On The Role…

NCT00356265 · University of Michigan, Other · Terminated

Key facts

NCT number NCT00356265
Title Alpha-Adrenoceptor Vascular Function In Chronic Kidney Disease Focus On The Role Of Endothelial Nitric Oxide
Official title Alpha-Adrenoceptor Vascular Function In Chronic Kidney Disease Focus On The Role Of Endothelial Nitric Oxide
Lead sponsor University of Michigan, Other
Collaborators National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NIH
Status Terminated
Study type Interventional
Conditions Chronic Kidney Disease, Hypertension
Intervention type Drug
Interventions Procedure: Regional phenylephrine arterial infusion
Enrollment 18
Start date Jul 1, 2006
Primary completion Nov 1, 2010
Completion Nov 1, 2010
First posted Jul 25, 2006
Last update posted Jan 23, 2018
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies